ResearcherKyushu UniversityActive in the last 2 years
Masami Miki
Matched on ORCID iD 0000-0002-4896-5157; OpenAlex author ID A5050871597. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. First author DOI 10.3390/cancers18132120↗
- Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of a… Co-author DOI 10.1111/ajco.13669↗
- Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic… Co-author DOI 10.3390/jcm11175084↗
- Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1. Co-author DOI 10.1007/s12328-020-01234-0↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masayuki Furukawa · 3 shared papers, 2022–2026 · strength 0.70
- Paper Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. DOI 10.3390/cancers18132120↗
- Paper Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse… DOI 10.1111/ajco.13669↗
- Paper Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Ther… DOI 10.3390/jcm11175084↗
- Lingaku Lee · 3 shared papers, 2022–2026 · strength 0.70
- Paper Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. DOI 10.3390/cancers18132120↗
- Paper Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse… DOI 10.1111/ajco.13669↗
- Paper Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Ther… DOI 10.3390/jcm11175084↗
- Nao Fujimori · 2 shared papers, 2021–2022 · strength 0.26
- Paper Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Ther… DOI 10.3390/jcm11175084↗
- Paper Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrin… DOI 10.1007/s12328-020-01234-0↗
- Yoshihiro Ogawa · 2 shared papers, 2021–2022 · strength 0.26
- Paper Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Ther… DOI 10.3390/jcm11175084↗
- Paper Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrin… DOI 10.1007/s12328-020-01234-0↗
- Masatoshi Murakami · 1 shared paper, 2022 · strength 0.14
- Tetsuhide Ito · 1 shared paper, 2021 · strength 0.12
- Hisato Igarashi · 1 shared paper, 2021 · strength 0.12
- Ryota Matsuda · 1 shared paper, 2021 · strength 0.12
- Yoshinao Oda · 1 shared paper, 2021 · strength 0.12
- Masafumi Nakamura · 1 shared paper, 2021 · strength 0.12
- Akihisa Ohno · 1 shared paper, 2021 · strength 0.12
- Takao Ohtsuka · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.